NCT00362960View on ClinicalTrials.gov

Olmesartan Medoxomil and Diabetic Nephropathy

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

September 30, 2004

Conditions

Type 2 Diabetes MellitusDiabetic NephropathyProteinuriaRenal Disease

Interventions

DRUG

Olmesartan medoxomil

DRUG

Losartan

Trial Locations (27)

Unknown

Frýdlant

Liberec

Prague

Tartu

Augsburg

Greifenstein-Beilstein

Hanover

Zwijndrecht

Grodzisk Mazowiecki

Krakow

Poznan

Pruszków

Płock

Torun

Warsaw

Watlack

Wołomin

Wroclaw

Banská Bystrica

Košice

Lučenec

Martin

Nitra

Nové Zámky

Šahy

Barcelona

Madrid

All Listed Sponsors

lead

Sankyo Pharma Gmbh

INDUSTRY

NCT00362960 - Olmesartan Medoxomil and Diabetic Nephropathy | Biotech Hunter | Biotech Hunter